Code	Modality	Target	Discovery Preclinical Phase 1 Phase 2 Phase 3	Partner
Oncology	DA-4505	Small molecule	AHR
	DA-3501 (AT-211)	ADC	Claudin 18.2
	DA-4507	Small molecule	GCN2
	DA-4511	Small molecule	SHP1
	DA-4515	Small molecule	TEAD
	DA-3101	Biologics	αFAP/IL-12v
	DA-4531	Small molecule	Undisclosed
	DA-4533	Small molecule	Undisclosed
	DA-4701	TPD	Undisclosed

	Code	Modality	Target	Discovery Preclinical Phase 1 Phase 2 Phase 3	Partner
Inflammatory/ Neurodegenerative Disease	DA-7503	Small molecule	Tau
	DA-7505	Small molecule	Undisclosed
	DA-1301	CGT	Undisclosed
	Inflammation Project	Small molecule	Undisclosed
	Inflammation Project	Small molecule	Undisclosed
	Inflammation Project	CGT	Undisclosed
	Inflammation Project	CGT	Undisclosed

	Code	Modality	Target	Discovery Preclinical Phase 1 Phase 2 Phase 3	Partner
Endocrine & Others	DA-8010	Small molecule	M3
	DA-1241	Small molecule	GPR119
	DA-1726	Peptide	GLP1R & GCGR

*TCR : T cell receptor, ICR : Immune checkpoint receptor